Cargando…
LncRNA PLAC2 down‐regulates RPL36 expression and blocks cell cycle progression in glioma through a mechanism involving STAT1
Current glioma therapies allow in situ delivery of cytotoxic drugs to the tumour; however, gliomas show early recurrence due to their highly proliferative character. Long non‐coding (lnc)RNAs play critical roles in tumorigenesis by controlling cell proliferation and cycling. However, the mechanism o...
Autores principales: | Hu, Yan‐Wei, Kang, Chun‐Min, Zhao, Jing‐Jing, Nie, Ying, Zheng, Lei, Li, Hai‐Xia, Li, Xin, Wang, Qian, Qiu, Yu‐Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742712/ https://www.ncbi.nlm.nih.gov/pubmed/28922548 http://dx.doi.org/10.1111/jcmm.13338 |
Ejemplares similares
-
A novel lncRNA, RPL34-AS1, promotes proliferation and angiogenesis in glioma by regulating VEGFA
por: Zhang, Dongzhi, et al.
Publicado: (2021) -
LncRNA PLAC 2 downregulated miR-21 in non-small cell lung cancer and predicted survival
por: Xia, Huan, et al.
Publicado: (2019) -
LncRNA PLAC2 Positively Regulates CDK2 to Promote Ovarian Carcinoma Cell Proliferation
por: He, Yuanqi, et al.
Publicado: (2020) -
LncRNA PLAC 2 Is Downregulated in Osteosarcoma and Regulates Cancer Cell Proliferation Through miR-93
por: Sun, Xiangran, et al.
Publicado: (2020) -
LncRNA PLAC 2 is Downregulated in Osteosarcoma and Regulates Cancer Cell Proliferation Through miR-93 [Erratum]
Publicado: (2020)